Nebido 1000 mg/ 4 ml, solution for injection.
4 ml solution containing 1000 mg testosterone undecanoate as active ingredient (corresponding to 631.5 mg testosterone) and benzyl benzoate and castor oil as excipients.
Testosterone replacement therapy of confirmed male hypogonadism.
Androgen-dependent carcinoma of the prostate or of the male mammary gland; past or present liver tumours; hypersensitivity to the active substance or to any of the excipients.
Nebido is injected every 10 to 14 weeks. Nebido is strictly for intramuscular injection and must be administered very slowly (over two minutes). Care should be taken to inject Nebido deeply into the gluteal muscle following the usual precautions for intramuscular administration. Special care must be taken to avoid intravasal injection. The first injection interval may be reduced to a minimum of 6 weeks. Nebido is not indicated for use in children and adolescents and it has not been evaluated clinically in males under 18 years of age.